J.P. Marvel Investment Advisors, LLC Moderna, Inc. Transaction History
J.P. Marvel Investment Advisors, LLC
- $607 Million
- Q2 2024
A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 46,112 shares of MRNA stock, worth $2.78 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
46,112
Previous 46,112
-0.0%
Holding current value
$2.78 Million
Previous $4.91 Million
11.44%
% of portfolio
0.9%
Previous 0.85%
Shares
13 transactions
Others Institutions Holding MRNA
# of Institutions
1,112Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.62 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.38 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.54 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$904 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$435 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $23.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...